Hyperfunctioning thyroid cancer: A five-year follow-up;Carcinoma de tireoide hiperfuncionante: Seguimento de cinco anos

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 54, Issue 1, 2010, Pages 78-80

  Azevedo, Monalisa Ferreira ^a   Casulari, Luiz Augusto ^a  

^a HOSPITAL UNIVERSITÁRIO DE BRASÍLIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CASE REPORT; COMPLICATION; FEMALE; HUMAN; HYPERTHYROIDISM; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; PAPILLARY CARCINOMA; THYROID NODULE; THYROID TUMOR;

CARCINOMA, PAPILLARY; FEMALE; HUMANS; HYPERTHYROIDISM; MIDDLE AGED; NEOPLASM, RESIDUAL; THYROID NEOPLASMS; THYROID NODULE;

EID: 77952841460     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302010000100013     Document Type: Article

References (18)

1. Paul SJ, Sisson JC. Thyrotoxicosis caused by thyroid cancer. Endocrinol Metab Clin North Am. 1990;19(3):593-612.
2. Calegaro JUM, Dias MSO, Bae SH, Moraes SS, Gomes EF, Casulari LA. Papillary carcinoma of the thyroid in an autonomously functioning nodule. Arq Bras Endocrinol Metab. 2003;47(6):739-43.
3. De Rosa G, Testa A, Maurizi M, Satta MA, Aimoni C, Artuso A, et al. Thyroid carcinoma mimicking a toxic adenoma. Eur J Nucl Med. 1990;17(3-4):179-84.
4. Als C, Gedeon P, Rosler H, Minder C, Netzer P, Laissue JA. Survival analysis of 19 patients with toxic thyroid carcinoma. J Clin Endocrinol Metab. 2002;87(9):4122-7.
5. Fuhrer D, Tannapfel A, Sabri O, Lamesch P, Paschke R. Two somatic TSH receptor mutations in a patient with toxic metastasising follicular thyroid carcinoma and non-functional lung metastases. Endocr Relat Cancer. 2003;10(4):591-600.
6. Gozu H, Avsar M, Bircan R, Sahin S, Ahiskanali R, Gulluoglu B, et al. Does a Leu 512 Arg thyrotropin receptor mutation cause an autonomously functioning papillary carcinoma? Thyroid. 2004;14(11):975-80.
7. Mazzaferri EL. Thyroid cancer and Graves' disease. J Clin Endocrinol Metab. 1990;70(4):826-9.
8. Chao TC, Lin JD, Jeng LB, Chen MF. Thyroid cancer with concurrent hyperthyroidism. Arch Surg. 1999;134(2):130-4.
9. Gross JL, Vasques Moraes I. Thyroid hormone-producing metastases in differentiated thyroid cancer. J Endocrinol Invest. 1996;19(1):21-4.
10. Zanella E, Rulli F, Sianesi M, Sciacchitano S, Danese D, Pontecorvi A, et al. Hyperthyroidism with concurrent thyroid cancer. Ann Ital Chir. 2001;72(3):293-7.
11. Rubenfeld S, Wheeler TM. Thyroid cancer presenting as a hot thyroid nodule: report of a case and review of the literature. Thyroidology. 1988;(1):63-8.
12. Kim TS, Asato R, Akamizu T, Harada D, Nakashima Y, Higashi T, et al. A rare case of hyperfunctioning papillary carcinoma of the thyroid gland. Acta Otolaryngol Suppl. 2007(557):55-7.
13. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature. 1993;365(6447):649-51.
14. Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, et al. Detection of thyroid-stimulating hormone receptor and Gsalpha mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med. 2001;78(12):684-91.
15. Camacho P, Gordon D, Chiefari E, Yong S, DeJong S, Pitale S, et al. A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism. Thyroid. 2000;10(11):1009-12.
16. Niepomniszcze H, Suarez H, Pitoia F, Pignatta A, Danilowicz K, Manavela M, et al. Follicular carcinoma presenting as autonomous functioning thyroid nodule and containing an activating mutation of the TSH receptor (T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid. 2006;16(5):497-503.
17. Russo D, Wong MG, Costante G, Chiefari E, Treseler PA, Arturi F, et al. A Val 677 activating mutation of the thyrotropin receptor in a Hurthle cell thyroid carcinoma associated with thyrotoxicosis. Thyroid. 1999;9(1):13-7.
18. Sobrinho-Simoes M, Maximo V, Rocha AS, Trovisco V, Castro P, Preto A, et al. Intragenic mutations in thyroid cancer. Endocrinol Metab Clin North Am. 2008;37(2):333-62, viii.